Skip to main content
IART
NASDAQ Industrial Applications And Services

Integra Q3 EPS Beat; 2026 Guidance Reaffirmed After $2.1B Refinancing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$13.25
Mkt Cap
$1.037B
52W Low
$8.7
52W High
$20.49
52W Position info
52% above low
Off High info
35% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

IART sits 52% above its 52-week low of $8.7.

Summary

Integra reported Q3 adjusted EPS of $0.59 on $411.2M revenue and reaffirmed 2026 guidance, while generating $96M of quarterly operating cash flow and cutting leverage to 3.8x following its $2.1B debt refinancing.


Key Events · Earnings and Guidance · IART

  • Q3 EPS Beats, Revenue Up 2.3%

    Revenue of $411.2M rose 2.3% reported and 2.5% organic; adjusted EPS was $0.59 versus $0.54 a year ago, and GAAP EPS swung to $0.19 from $(0.07).

  • 2026 Guidance Reaffirmed

    Full-year revenue of $1.634B-$1.654B and adjusted EPS of $2.30-$2.40, unchanged from the October 2 pre-announcement. Q4 is guided to $413M-$433M revenue (-5.2% to -0.5%) and $0.61-$0.71 adjusted EPS.

  • Cash Flow Strong, Leverage 3.8x

    Operating cash flow of $96.0M in the quarter brought nine-month operating cash flow to $128.6M versus $38.6M a year ago; net debt was $1.5B with total liquidity of about $559M.

  • Refinancing Raises Interest Cost

    The $2.1B refinancing closed October 19 with a 9.5% coupon on $450M of 2033 notes; management expects the effective rate near the high end of the 100-200bp increase previously flagged.


Analysis · IART · Industrial Applications And Services

The headline is the EPS beat, but the real story is cash and balance sheet. Integra delivered Q3 adjusted EPS of $0.59 versus $0.54 a year ago on revenue of $411.2M, up 2.3%, and held its full-year outlook at $1.634B-$1.654B in revenue and $2.30-$2.40 in adjusted EPS — the same ranges it pre-announced on October 2. The quarter's substance: $96.0M of operating cash flow, net debt down to $1.5B and leverage at 3.8x, plus the just-completed $2.1B refinancing that pushed maturities out. The trade-off is cost — the new debt carries a 9.5% coupon and management expects the effective rate near the high end of the 100-200bp increase it flagged, and amended covenants only temporarily lift the leverage ceiling before stepping down to 4.25x in 2027. With Q4 guided to a revenue decline of as much as 5.2% on the Cincinnati flood and softer Tissue Reconstruction, the question is whether cash generation can outrun a higher interest bill while the plant recovers.

How filings like this one have moved

In the 30 days to Oct 21, 2026, 29.2% of the 1544 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IART was trading at $13.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $8.70 to $20.49. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IART - Latest Insights

IART
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.25
Real-time Price: $13.25 info
Change: $0 (0%) info
Market Cap: $1.037B info
IART
Oct 19, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.45
Real-time Price: $13.25 info
Change: -$0.200 (-1%) info
Market Cap: $1.037B info
IART
Oct 09, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.44
Real-time Price: $13.25 info
Change: -$0.190 (-1%) info
Market Cap: $1.037B info
IART
Oct 09, 2026, 5:22 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $13.44
Real-time Price: $13.25 info
Change: -$0.190 (-1%) info
Market Cap: $1.037B info
IART
Oct 02, 2026, 9:08 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $14.30
Real-time Price: $13.25 info
Change: -$1.05 (-7%) info
Market Cap: $1.037B info